MACROGENICS INC financial data

Symbol
MGNX on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 461% % 32%
Quick Ratio 19% % 692%
Debt-to-equity 302% % 110%
Return On Equity -98% % -9.9%
Return On Assets -30% % -9%
Operating Margin -49% % 34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63,555,837 shares 0.74%
Common Stock, Shares, Outstanding 63,318,613 shares 0.79%
Entity Public Float $73,900,000 USD -72%
Common Stock, Value, Issued $633,000 USD 0.8%
Weighted Average Number of Shares Outstanding, Basic 63,155,096 shares 0.85%
Weighted Average Number of Shares Outstanding, Diluted 63,155,096 shares 0.85%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $149,500,000 USD -0.31%
Research and Development Expense $147,172,000 USD -17%
General and Administrative Expense $39,160,000 USD -45%
Costs and Expenses $222,341,000 USD -15%
Operating Income (Loss) $72,841,000 USD 34%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,822,000 USD -70%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $74,620,000 USD -11%
Earnings Per Share, Basic -1.18 USD/shares -10%
Earnings Per Share, Diluted -1.18 USD/shares -10%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $57,217,000 USD -69%
Accounts Receivable, after Allowance for Credit Loss, Current $13,373,000 USD 210%
Inventory, Net $7,910,000 USD
Assets, Current $219,941,000 USD 1.1%
Property, Plant and Equipment, Net $12,625,000 USD -30%
Operating Lease, Right-of-Use Asset $22,895,000 USD -6.6%
Other Assets, Noncurrent $1,385,000 USD -11%
Assets $256,846,000 USD -1.8%
Accounts Payable, Current $4,787,000 USD -4.5%
Accrued Liabilities, Current $22,230,000 USD -24%
Contract with Customer, Liability, Current $10,302,000 USD -56%
Liabilities, Current $43,115,000 USD -22%
Contract with Customer, Liability, Noncurrent $55,840,000 USD 0.61%
Operating Lease, Liability, Noncurrent $31,585,000 USD -3.1%
Other Liabilities, Noncurrent $1,052,000 USD -47%
Liabilities $201,255,000 USD 38%
Retained Earnings (Accumulated Deficit) $1,244,338,000 USD -6.4%
Stockholders' Equity Attributable to Parent $55,591,000 USD -52%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $67,001,000 USD -44%
Liabilities and Equity $256,846,000 USD -1.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $46,890,000 USD -2.7%
Net Cash Provided by (Used in) Financing Activities $282,000 USD -214%
Net Cash Provided by (Used in) Investing Activities $9,902,000 USD -60%
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $37,270,000 USD -81%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $57,217,000 USD -69%
Deferred Tax Assets, Valuation Allowance $410,103,000 USD 2.2%
Deferred Tax Assets, Gross $417,823,000 USD 1.9%
Operating Lease, Liability $36,762,000 USD -1.9%
Payments to Acquire Property, Plant, and Equipment $529,000 USD -64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $74,592,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid $65,297,000 USD -7.4%
Property, Plant and Equipment, Gross $108,432,000 USD 1.5%
Operating Lease, Liability, Current $5,177,000 USD 6.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,258,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,507,000 USD 6.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28,535,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $7,413,000 USD 18%
Unrecognized Tax Benefits $8,339,000 USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,346,000 USD -14%
Depreciation, Depletion and Amortization $1,771,000 USD -3.8%
Deferred Tax Assets, Net of Valuation Allowance $7,720,000 USD -13%
Share-based Payment Arrangement, Expense $14,286,000 USD -51%
Interest Expense $4,211,000 USD 270%